Taxol claims deadline extended again

Consumers who used the anti-cancer drug Taxol (or its generic equivalent, paclitaxel) now have one additional month to file claims in an antitrust case. The new deadline is Feb. 29, 2004.

Nationally, $12.5 million is available to consumers who were overcharged for the drug by manufacturer Bristol-Myers Squibb. Patients would have received Taxol during treatment for cancer of the breast, ovaries, lung or other cancers.

Submit claims by contacting the Taxol settlement administrator at 1-800-659-7609 or by visiting the Taxol claims web site.